Buy Stocks Easy | About Us
August 16, 2022
Buy Stocks Easy | Online Stocks

KMPH


Buy KemPharm, Inc. Stock (symbol: KMPH) Easy Online

Company Name: KemPharm, Inc.

Symbol: KMPH

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2015

KMPH Current Share Price

Today's KMPH ( KemPharm, Inc. ) opening price: $0.3400

Yesterday's KMPH ( KemPharm, Inc. ) closing price: $0.3385

KemPharm, Inc. Stock ( symbol: KMPH ) Price Chart since IPO (2015):

12 Months KemPharm, Inc. Stock ( symbol: KMPH ) Price Chart

Popular Questions about KemPharm, Inc. Public Stock ( KMPH )

A: KemPharm, Inc. stock symbol (also called stock or share ticker) is KMPH

A: KemPharm, Inc. IPO (Initial Public Offering) took place on 2015

A: KemPharm, Inc.'s stock (KMPH symbol) price at ther IPO (initial Public Offering) was $0.3400

Q: Is KMPH stock worth buying at the moment?

A: The KMPH stock performance since 2019 are rather disappointing. If you had bought 1 share of KemPharm, Inc. stock (symbol: KMPH) at the beginning of 2019, at the opening share price of $2.6100, you would be left with exactly $0.3400 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy KemPharm, Inc. Stock Easy Online

KemPharm, Inc. Stock Ticker Price Chart since IPO:





KemPharm, Inc. Stock Price Yesterday



 


KemPharm, Inc. Stock Price – Last Week




 


KemPharm, Inc. Stock Price – Last Month




 


KemPharm, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/18/1962120/0/en/KemPharm-Announces-Debt-Restructuring-with-Deerfield-and-Delaware-Street-Capital.html
                            

                                
KemPharm Announces Debt Restructuring with Deerfield and Delaware Street Capital

                                
                                
Principal and Interest Payments on Outstanding Debt in Principal Am...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4306878-kempharm-inc-kmph-ceo-travis-mickle-q3-2019-results-earnings-call-transcript
                            

                                
KemPharm, Inc. (KMPH) CEO Travis Mickle on Q3 2019 Results - Earnings Call Transcript

                                
                                
KemPharm, Inc. (KMPH) CEO Travis Mickle on Q3 2019 Results - Earnin...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/22/1933655/0/en/KemPharm-Presents-Study-Highlighting-Patient-Friendly-Dosing-Properties-of-KP415-at-the-66th-Annual-American-Academy-of-Child-Adolescent-Psychiatry-Meeting.html
                            

                                
KemPharm Presents Study Highlighting Patient-Friendly Dosing Properties of KP415 at the 66th Annual American Academy of Child & Adolescent Psychiatry Meeting

                                
                                
Data Demonstrate that KP415 Can Be Administered without Regard to F...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/20/1918757/0/en/KemPharm-Provides-Updates-Regarding-its-Board-of-Directors.html
                            

                                
KemPharm Provides Updates Regarding its Board of Directors

                                
                                
CELEBRATION, Fla., Sept.  20, 2019  (GLOBE NEWSWIRE) -- KemPharm, I...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/17/1916679/0/en/KemPharm-to-Participate-in-the-Oppenheimer-Fall-Summit-Focused-on-Specialty-Pharma-Rare-Diseases.html
                            

                                
KemPharm to Participate in the Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Diseases

                                
                                
CELEBRATION, Fla., Sept.  17, 2019  (GLOBE NEWSWIRE) -- KemPharm, I...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/05/1911424/0/en/KemPharm-to-Present-at-the-21st-Annual-Global-Investment-Conference-Sponsored-By-H-C-Wainwright-Co.html
                            

                                
KemPharm to Present at the 21st Annual Global Investment Conference, Sponsored By H.C. Wainwright & Co.

                                
                                
CELEBRATION, Fla., Sept.  05, 2019  (GLOBE NEWSWIRE) -- KemPharm, I...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/04/1910726/0/en/KemPharm-Announces-Entry-into-Definitive-Collaboration-and-License-Agreement-for-its-ADHD-Candidates-KP415-and-KP484-with-an-Affiliate-of-Gurnet-Point-Capital.html
                            

                                
KemPharm Announces Entry into Definitive Collaboration and License Agreement for its ADHD Candidates, KP415 and KP484, with an Affiliate of Gurnet Point Capital

                                
                                
Up to a Total of $493 Million in Upfront, Sales and Development Mil...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/460645/implied-volatility-surging-for-kempharm-kmph-stock-options
                            

                                
Implied Volatility Surging for KemPharm (KMPH) Stock Options

                                
                                
Investors need to pay close attention to KemPharm (KMPH) stock base...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4249592-kempharm-will-optimism-win?source=feed_tag_long_ideas
                            

                                
KemPharm: Will Optimism Win?

                                
                                
KemPharm on Wednesday gave a presentation on its Apadaz commerciali...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.